ZYME Competitors & Alternatives
Compare Zymeworks Inc. Common Stock with similar stocks in the same industry
Biotechnology
ZYME
Main Stock$27.94
Tradestie Score
64
Market Cap
$1.28B
Revenue Growth
-0.9%
Analyst Upside
+43.4%
Top Competitors
223 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
GLPG
Galapagos NV
|
$28.42
|
$2.31B | 5.0 | 61 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.41
|
$2.23B | - | 54 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$14.04
|
$2.22B | - | 54 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$40.89
|
$2.21B | - | 60 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$20.06
|
$2.18B | - | 57 | Compare |
|
MESO
Mesoblast Limited American Depositary Shares
|
$15.22
|
$2.08B | - | 47 | Compare |
|
SRPT
Sarepta Therapeutics,, Inc. Common Stock
|
$21.07
|
$2.02B | - | 54 | Compare |
|
NTLA
Intellia Therapeutics, Inc
|
$13.20
|
$2.01B | - | 53 | Compare |
|
COGT
Cogent Biosciences, Inc. Common Stock
|
$36.34
|
$1.97B | - | 62 | Compare |
|
OCUL
Ocular Therapeutix, Inc.
|
$9.32
|
$1.92B | - | 60 | Compare |
More ZYME Analysis
Data updated: Apr 29, 2026 | Industry: Biotechnology (SIC 2834)
223 stocks in this industry